PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32679023-0	2021	Activation of Myosin Phosphatase by Epigallocatechin-Gallate Sensitizes THP-1 Leukemic Cells to Daunorubicin.	Daunorubicin	96-108	GLI family zinc finger 2	Homo sapiens	72-77	
32679023-5	2021	METHODS: THP-1 leukemic cells were treated with EGCG and Daunorubicin (DNR) and cell viability was analyzed.	Daunorubicin	57-69	GLI family zinc finger 2	Homo sapiens	9-14	
32679023-5	2021	METHODS: THP-1 leukemic cells were treated with EGCG and Daunorubicin (DNR) and cell viability was analyzed.	Daunorubicin	71-74	GLI family zinc finger 2	Homo sapiens	9-14	
31506393-7	2019	The combined treatment of 3-BP and DNR showed synergistic effect on the growth inhibition of K-562 and THP-1 cells.	Daunorubicin	35-38	GLI family zinc finger 2	Homo sapiens	103-108	
32098672-6	2020	After co-culture of NB4 and THP1 with MSCs pretreated with 3 MA or ATG5 knockdown respectively, the sensitivity of AML cell lines to daunorubicin and doxorubicin was improved in a dose- and time-dependent manner compared to controls.	Daunorubicin	133-145	GLI family zinc finger 2	Homo sapiens	28-32	
17052966-5	2006	After 48 and 72 hours treatment with daunorubicin and Ara-C, respectively, increased cell death was observed in THP-1 cells that were pretreated with FK866, as compared to cells exposed to antineoplastic drugs alone.	Daunorubicin	37-49	GLI family zinc finger 2	Homo sapiens	112-117	
24830852-7	2014	Daunorubicin (DNR) demonstrated a 2.2- and 3.5-fold higher cytotoxicity with the HL formulation and a 1.2- and 2.0-fold higher cytotoxicity with the LL formulation compared to the unmodified liposomal formulation in THP-1 and NB4 cells, respectively.	Daunorubicin	0-12	GLI family zinc finger 2	Homo sapiens	216-221	
24830852-7	2014	Daunorubicin (DNR) demonstrated a 2.2- and 3.5-fold higher cytotoxicity with the HL formulation and a 1.2- and 2.0-fold higher cytotoxicity with the LL formulation compared to the unmodified liposomal formulation in THP-1 and NB4 cells, respectively.	Daunorubicin	14-17	GLI family zinc finger 2	Homo sapiens	216-221	
18755268-0	2008	Myosin phosphatase interacts with and dephosphorylates the retinoblastoma protein in THP-1 leukemic cells: its inhibition is involved in the attenuation of daunorubicin-induced cell death by calyculin-A.	Daunorubicin	156-168	GLI family zinc finger 2	Homo sapiens	85-90	
18755268-3	2008	It is shown that pretreatment of THP-1 leukemic cells with calyculin-A (CL-A), a cell-permeable phosphatase inhibitor, attenuated daunorubicin (DNR)-induced cell death and resulted in increased pRb phosphorylation and protection against proteolytic degradation.	Daunorubicin	130-142	GLI family zinc finger 2	Homo sapiens	33-38	
18755268-3	2008	It is shown that pretreatment of THP-1 leukemic cells with calyculin-A (CL-A), a cell-permeable phosphatase inhibitor, attenuated daunorubicin (DNR)-induced cell death and resulted in increased pRb phosphorylation and protection against proteolytic degradation.	Daunorubicin	144-147	GLI family zinc finger 2	Homo sapiens	33-38